Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Drugs:Dementia

Senior couple smiling and enjoying each other's company indoors.

Korsana’s Alzheimer’s Treatment Promises Safer Care — But When?

February 20, 2026 No Comments

A safer Alzheimer’s treatment may be on the horizon — but families still have meaningful choices today.

Doctor shows patient brain scans on tablet

How Doctors Decide Who Qualifies for Leqembi

February 19, 2026 No Comments

Many diagnosed patients won’t qualify — here are the
7 medical criteria.

ai generated, neuron, brain, synapses, biology, science, thinking, cell, anatomy, nerves, neural, mind, dendrites, connection, physiology, neurology

How Lecanemab Clears Amyloid and Slows Alzheimer’s—even as Tau Spreads

February 5, 2026 1 Comment

New early-onset Alzheimer’s data show that lecanemab can slow functional decline—even while tau continues to spread in the brain. The research helps explain how amyloid-lowering treatments may still preserve daily life, despite the disease’s complexity.

What 400 Alzheimer’s Patients Gained From Leqembi and Kisunla

January 29, 2026 No Comments

In a one-hour seminar, a leading neurologist answers the most important questions families ask about what these new therapies can realistically deliver — from effectiveness and safety to eligibility, infusion logistics, cost, and access.

Happy senior couple walking outdoors, holding colorful flowers. A delightful moment capturing love and togetherness.

Leqembi Likes Asia’s Genes. Why?

December 30, 2025 No Comments

New evidence suggests genetics—not geography—may explain why Leqembi causes fewer ARIA brain side effects in parts of Asia, and what that means for families everywhere.

"Alzheimer's Treatment Demand" chart behind patient, caregiver and doctor.

Leqembi Prescriptions Could Rise Sharply. Why?

December 21, 2025 No Comments

Alzheimer’s treatment eligibility may be far larger than previously thought. A major Nature study using blood tests suggests millions more older adults could qualify for treatment than current use reflects. As diagnosis becomes easier, demand for drugs like Leqembi could shift sharply.

Exelon (Rivastigmine Transdermal Patch for Alzheimer's)

Rivastigmine Alzheimer’s Patch: New Research, Better Comfort

December 11, 2025 No Comments

New studies highlight smoother tolerability, easier routines, and practical safety updates that make the rivastigmine patch an increasingly caregiver-friendly option.

One Weight-Loss Drug Slowed Alzheimer’s, Two Didn’t. That’s Good News.

December 9, 2025 No Comments

Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.

Happy senior couple sharing a smile in a cozy outdoor setting, capturing a moment of love and connection.

Lecanemab Can Delay Alzheimer’s 8 Years: New Data, New Hope

December 7, 2025 No Comments

New long-term data suggests lecanemab could delay the shift from mild memory loss to moderate Alzheimer’s by up to eight years—offering families precious time and renewed hope.

cyber brain, computer, brain, information, the internet, technology, digital, jobs, remote, web3, network, electric circuit, artificial intelligence, brain, brain, brain, web3, artificial intelligence, artificial intelligence, artificial intelligence, artificial intelligence, artificial intelligence

Leqembi: Slowing Alzheimer’s — What You Need to Know

November 16, 2025 2 Comments

Leqembi is one of the first Alzheimer’s treatments proven to slow decline. A new MRI study helps explain what it can—and cannot—do in the brain’s early months, offering clearer expectations for caregivers.

Human Growth Hormone Molecule alongside Human Brain, Pituitary Gland Highlighted

Catching Alzheimer’s: News or Nonsense?

April 25, 2026

VIDEO + ARTICLE:
Everyone knows Alzheimer’s is not catchy, but a new study shows it might be “transmissible”. Learn the difference and find out what it means to research.

Grandmother in black and white striped shirt hugging girl in black and white striped shirt

A Grandchild for One Day Keeps Dementia Away

April 24, 2026

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?